PTA-Adhoc: Dr. Hönle AG: Joint Venture of Honle Group with SKC Co. Ltd.
Adhoc announcement according to article 15 WpHG
Gräfelfing/München (pta025/20.05.2015/17:07) - The Dr. Hönle AG subsidiary, Panacol Elosol GmbH, concluded today a cooperation agreement with SKC Co. Ltd.. The agreement expresses the mutual will of both parties to establish a joint enterprise in Korea with a view to selling and marketing adhesives and the intent at a later date to develop and produce adhesive products. Panasol Elosol GmbH is to hold a 51 % stake while SKC Co. Ltd. will hold 49% of the shares in the joint company.
SKC Co. Ltd. is part of SK Group, one of the largest conglomerates in South Korea.
Dr. Hönle AG is a listed technology company with head office in Gräfelfing, near Munich. With a staff level of more than 500 employees, the Hönle Group is one of the world's leading systems suppliers in the UV technology segment. The equipment and systems are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The company's business activities also include the development and sale of industrial adhesives and sealings. In addition, the group manufactures UV lamps that are used in water sterilisation and for other applications, and produces tubing and semi-finished goods made of quartz glass that are used by various branches of industry. The Hönle Group is represented worldwide at 69 locations in 27 countries by own companies and sales partners.
emitter: Dr. Hönle AG
address: Lochhamer Schlag 1, 82166 Gräfelfing/München
contact person: Peter Weinert
phone: +49 89 85608-173
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin